“…Despite the foreseeable advent of pharmacologic treatment aiming at resolution of steatohepatitis and regression of fibrosis, lifestyle interventions will remain the foundation of treatment of MASLD 3 . To increase awareness about diet and eating habits, behavioural therapy has been established as an important intervention to promote these lifestyle recommendations 4 . However, despite the positive results of lifestyle interventions in the short term, they remain challenging in clinical practice in the long term due to a lack of adherence and high attrition rates 5,6 …”